将患者的需求和观点纳入额外的降低风险措施和其他药物监管成果 - - 框架和实施路线图
Linda Smeding1, Robert Massouh2, Farai Moyo2
1GSK, Avenue Fleming 20, Wavre, 1300, Belgium. linda.x.smeding@gsk.com.
患者参与药物监测对于有效降低风险至关重要. 一个新的框架支持销售许可证持有人 (MAHs) 系统地将PE纳入风险管理,增强以患者为中心的药物安全性.
科学领域:
- 药物监督 药物监督 药物监督
- 患者参与 患者参与
- 风险管理 风险管理
背景情况:
- 现有的指导方针强调患者参与药品生命周期,特别是风险最小化策略.
- 营销许可证持有人 (MAHs) 在药物监督和风险管理系统中采用患者参与 (PE) 的系统框架存在差距.
- 患者审查对额外的风险最小化材料的影响需要进一步探索.
更多相关视频
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Biopharmaceutics and Pharmacokinetics: Overview
Preclinical Development: Overview
